Health Care • Biotechnology: In Vitro & In Vivo Diagnostic Substances
$11.66 ▼ -0.81
(-6.50%)
MKT CAP: $1.75B • VOL: 3.88M
52W L $8 52W H $18
DISCLOSED BUY FLOW
$0
DISCLOSED SELL FLOW
$0
13F HEDGE FUND FILINGS
0 DISCLOSURES
CONGRESSIONAL STOCK ACT
0 FILINGS
NTLA // SEC FORM 4 INSIDERS, 13F WHALES & POLITICIAN LEDGER (OWN <GO>)
WHALE DIRECTORY <13F>
| FILING DATE | FILER / INSTITUTION | CATEGORY | ACTION | SHARES | EXEC PRICE | TOTAL VALUE | DOSSIER |
|---|---|---|---|---|---|---|---|
| 2025-02-14 | Citadel Advisors LLC (13F-HR) Institutional Investment Manager | HEDGE_FUND | BUY | 425.0K | $11.19 | $4.8M | TRACK <GO> |
| 2025-02-04 | Executive Officer Form 4 Trust EVP & Chief Financial Officer | INSIDER | SELL | 18.5K | $11.78 | $217.9K | TRACK <GO> |
| 2025-01-28 | Renaissance Technologies LLC 13F Quantitative Holdings | HEDGE_FUND | BUY | 190.0K | $10.96 | $2.1M | TRACK <GO> |